Literature DB >> 10416131

Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules.

P Angelisová1, K Drbal, J Cerný, I Hilgert, V Horejsí.   

Abstract

The CDw108 glycoprotein is expressed on the surface of some leukemic cell lines, erythrocytes and on activated lymphocytes. Its surface expression is rapidly upregulated following various activating stimuli (PHA, PWM, Con A, PMA, anti-CD3) and subsequently gradually decreases. The molecule is anchored in the membrane via glycosylphosphatidylinositol (GPI) moiety, it has molecular mass of 75-80 kDa and pI of 5.0-5.5. Endoglycosidase F and H reduce its apparent size as determined by SDS PAGE by approx. 15 and 22 kDa, respectively. It is a component of large, detergent-resistant GPI-complexes associated with protein kinases. In addition to the previously described identity of CDw108 with the JMH blood group antigen, we demonstrate here its identity to the previously described glycoprotein recognized by monoclonal antibodies H105 and KS.2, and exclude its identity with another GPI-anchored glycoprotein of similar size, melanotransferrin (gp97).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416131     DOI: 10.1016/s0171-2985(99)80073-4

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  Secretome signature of invasive glioblastoma multiforme.

Authors:  Catherine A Formolo; Russell Williams; Heather Gordish-Dressman; Tobey J MacDonald; Norman H Lee; Yetrib Hathout
Journal:  J Proteome Res       Date:  2011-05-31       Impact factor: 4.466

2.  Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines.

Authors:  Stephane Esnault; Elizabeth A Kelly; Mats W Johansson; Lin Ying Liu; Shih-Tsung Han; Moneeb Akhtar; Nathan Sandbo; Deane F Mosher; Loren C Denlinger; Sameer K Mathur; James S Malter; Nizar N Jarjour
Journal:  Clin Immunol       Date:  2013-11-23       Impact factor: 3.969

3.  Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia.

Authors:  Julio César Morote-Garcia; Daniel Napiwotzky; David Köhler; Peter Rosenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

4.  Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.

Authors:  Joshua Ghofrani; Olivier Lucar; Haley Dugan; R Keith Reeves; Stephanie Jost
Journal:  Eur J Immunol       Date:  2019-05-02       Impact factor: 5.532

Review 5.  Red cell receptors as access points for malaria infection.

Authors:  Nichole D Salinas; Niraj H Tolia
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 6.  Semaphorin7A: branching beyond axonal guidance and into immunity.

Authors:  Ramon Garcia-Areas; Stephania Libreros; Vijaya Iragavarapu-Charyulu
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

7.  Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP.

Authors:  S Josefin Bartholdson; Leyla Y Bustamante; Cecile Crosnier; Steven Johnson; Susan Lea; Julian C Rayner; Gavin J Wright
Journal:  PLoS Pathog       Date:  2012-11-15       Impact factor: 6.823

8.  Identification and Evaluation of New Immunoregulatory Genes in Mesenchymal Stromal Cells of Different Origins: Comparison of Normal and Inflammatory Conditions.

Authors:  Mohammad Fayyad-Kazan; Mehdi Najar; Hussein Fayyad-Kazan; Gordana Raicevic; Laurence Lagneaux
Journal:  Med Sci Monit Basic Res       Date:  2017-03-24

9.  Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling.

Authors:  Hameeda Sultana; Girish Neelakanta; Harald G Foellmer; Ruth R Montgomery; John F Anderson; Raymond A Koski; Ruslan M Medzhitov; Erol Fikrig
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

Review 10.  The semaphorins.

Authors:  Umar Yazdani; Jonathan R Terman
Journal:  Genome Biol       Date:  2006-03-30       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.